PAVmed Announces Efforts To Regain Nasdaq Compliance, Including Lucid Diagnostics Deconsolidation From Financials And Appointment Of Sundeep Agrawal To Board; Deconsolidation Increases PAVmed's Stockholder Equity While Retaining Largest Shareholder...
PAVmed Announces Efforts To Regain Nasdaq Compliance, Including Lucid Diagnostics Deconsolidation From Financials And Appointment Of Sundeep Agrawal To Board; Deconsolidation Increases PAVmed's Stockholder Equity While Retaining Largest Shareholder...
pavmed宣佈努力恢復納斯達克的合規性，包括從財務報表中除去Lucid Diagnostics並任命Sundeep Agrawal加入董事會；從合併報表中除去有助於增加pavmed的股東權益，同時保留最大股東...
PAVmed Announces Efforts To Regain Nasdaq Compliance, Including Lucid Diagnostics Deconsolidation From Financials And Appointment Of Sundeep Agrawal To Board; Deconsolidation Increases PAVmed's Stockholder Equity While Retaining Largest Shareholder Status In Lucid
pavmed宣佈努力恢復納斯達克的合規性，包括從財務報表中取消Lucid診斷公司，並任命Sundeep Agrawal加入董事會；取消合併會增加pavmed的股東權益，同時保留在Lucid中最大的股東地位。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。